Integre Asset Management’s Medifast MED Stock Holding History

Integre Asset Management’s Portfolio MED Stock Details MED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	$208K	Sell	1,896 -1,030	-35%	-$99.7K	0.12%	110
2019 Q3	$303K	Sell	2,926 -26,497	-90%	-$2.85M	0.18%	76
2019 Q2	$3.77M	Buy	29,423 +22	+0.1%	+$3.06K	2.16%	14
2019 Q1	$3.75M	Buy	+29,401	New	+$3.73M	2.27%	12
2018 Q4	–	Sell	-994	Closed	-$220K	–	104
2018 Q3	$220K	Buy	+994	New	+$202K	0.13%	91
2018 Q2	–	Sell	-4,451	Closed	-$416K	–	103
2018 Q1	$416K	Buy	4,451 +54	+1%	+$4.04K	0.27%	63
2017 Q4	$307K	Buy	4,397 +160	+4%	+$10.6K	0.18%	76
2017 Q3	$252K	Buy	+4,237	New	+$211K	0.17%	83

Other funds holding MED

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Engaged Capital Newport Beach, California $303M AUM 2.09% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

MVP

Miller Value Partners Sarasota, Florida $383M AUM 38.57% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

RHJA

Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return

PAMU

Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Integre Asset Management's MED Position: Q4 2019 in Review

Integre Asset Management reduced its Medifast (MED) stake by 35% in Q4 2019, selling an estimated $99.7K and leaving 1,896 shares worth $208K. The position accounts for 0.12% of the portfolio, ranked #110.

Integre Asset Management first reported a position in MED in Q3 2017 and has held it in 8 quarters since. The position peaked at $3.77M in Q2 2019. 219 funds tracked by Wall St. Rank hold MED as of Q4 2019.

Integre Asset Management held 1,896 shares of Medifast worth $208K as of Q4 2019.
Integre Asset Management sold 1,030 Medifast shares in Q4 2019, an estimated $99.7K.
Medifast made up 0.12% of Integre Asset Management's portfolio in Q4 2019, its #110 holding.
Integre Asset Management first reported a position in Medifast in Q3 2017 and has held it in 8 quarters since.
Integre Asset Management's Medifast position peaked at $3.77M in Q2 2019.
219 funds tracked by Wall St. Rank held Medifast as of Q4 2019.

Based on Integre Asset Management's 13F filing for Q4 2019, filed 14 Feb 2020.